InfraReDx, Inc. Company Profile
InfraReDx, Inc., headquartered in Burlington, Massachusetts, is a privately-funded medical device company founded in 1998 and focused on intravascular characterization of disease in the coronary arteries. InfraReDx is the maker of the LipiScan(TM) system, a novel near-infrared (NIR) spectroscopy catheter that can detect the lipid core coronary plaques suspected to cause most heart attacks and known to complicate stenting procedures. For more information, visit www.infraredx.com.
News Articles
Former Indus exec joins Infraredx as chief financial officer
Michael Guarasci has been appointed to serve as chief financial officer of Infraredx, a provider of coronary imaging systems. -More-
Collaboration to Develop Catheterization Lab Integration for Vessel Characterization
Philips Healthcare and Infraredx have signed a joint development and collaboration agreement that involves incorporating Infraredx’s true vessel...
Royal Philips Electronics and Infraredx Inc., a medical device company committed to advancing the diagnosis and management of coronary artery and other vascular diseases, announced the availability of...
[Nipro] gets Japanese rights to [InfraReDx]'s {TVC Imaging System}
[Nipro Corp.] has licensed exclusive Japanese distribution rights to cardiovascular device developer [InfraReDx Inc.]’s {TVC Imaging System}, which helps in the diagnosis of coronary artery disease....
Nipro to distribute Infraredx TVC intravascular imaging system in Japan
Nipro has entered into a five-year agreement to distribute Infraredx's TVC intravascular imaging system for true vessel characterization of coronary artery disease in Japan.
[InfraReDx], [Royal Philips] integrate cardiovascular systems
[InfraReDx Inc.] (medical devices for vascular diseases) and [Royal Philips Electronics NV] have signed an agreement under which the companies will integrate InfraReDx’s {True Vessel Characterizatio...
Infraredx Appoints Michael Guarasci as Chief Financial Officer
Infraredx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery and other vascular diseases, today announced the appointmen...
Drugs and Medications
None
PubMed Articles
None
Clinical Trials
None
Companies
InfraReDx, Inc., headquartered in Burlington, Massachusetts, is a privately-funded medical device company founded in 1998 and focused on intravascular characterization of disease in the coronary arter...
More Information about "InfraReDx, Inc." on BioPortfolio
We have published hundreds of InfraReDx, Inc. news stories on BioPortfolio along with dozens of InfraReDx, Inc. Clinical Trials and PubMed Articles about InfraReDx, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of InfraReDx, Inc. Companies in our database. You can also find out about relevant InfraReDx, Inc. Drugs and Medications on this site too.
